Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Completed 4Recruiting 1

Sponsor Class

OTHER 43INDUSTRY 6OTHER_GOV 4NIH 1NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 107Neoplasms 80Colorectal Neoplasms 54Uterine Cervical Neoplasms 29Stomach Neoplasms 29Lung Neoplasms 27Rectal Neoplasms 25Prostatic Neoplasms 25Colonic Neoplasms 24Polycystic Ovary Syndrome 22Pancreatic Neoplasms 22Head and Neck Neoplasms 17Endometrial Neoplasms 17Carcinoma, Non-Small-Cell Lung 16Carcinoma, Hepatocellular 16Pain 15Neoplasm Metastasis 15Motor Activity 15Esophageal Neoplasms 15Ovarian Neoplasms 13Urinary Bladder Neoplasms 11Lymphoma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Pain, Postoperative 10Melanoma 10Thyroid Neoplasms 9Pilonidal Sinus 9Multiple Myeloma 9Gastrointestinal Neoplasms 9Sarcopenia 8

Interventions

avelumab 1Paclitaxel 1Ifosfamide 1Everolimus 1Disulfiram 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × OTHER_GOV × Neoplasms, Germ Cell and Embryonal × Clear all
NCT03950830 2023-10-04

DISGCT

National Cancer Institute, Slovakia

Phase 2 Completed
12 enrolled

Neoplasms, Germ Cell and Embryonal

NCT02414685 2020-08-07

TIP

National Cancer Institute, Slovakia

Phase 2 Completed
19 enrolled

Neoplasms, Germ Cell and Embryonal

NCT03403777 2019-03-05

Avelumab in Refractory Testicular Germ Cell Cancer.

National Cancer Institute, Slovakia

Phase 2 Completed
8 enrolled
Genitourinary

Gonadal Disorders, Neoplasms, Neoplasms, Germ Cell and Embryonal, Testicular Diseases, Testicular Neoplasms

NCT01466231 2016-01-12

Everolimus in Refractory Testicular Germ Cell Cancer

National Cancer Institute, Slovakia

Phase 2 Completed
15 enrolled

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡